CalciMedica, Inc.
CALC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $519 |
| Gross Profit | $0 | $0 | $0 | -$519 |
| % Margin | – | – | – | – |
| R&D Expenses | $14,478 | $15,859 | $8,350 | $18,903 |
| G&A Expenses | $9,726 | $22,216 | $5,843 | $17,044 |
| SG&A Expenses | $9,726 | $22,216 | $5,843 | $17,044 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$519 |
| Operating Expenses | $24,204 | $38,075 | $14,193 | $35,428 |
| Operating Income | -$24,204 | -$38,075 | -$14,193 | -$35,947 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $10,504 | $3,718 | $6,369 | $126 |
| Pre-Tax Income | -$13,700 | -$34,357 | -$7,824 | -$35,821 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$13,700 | -$34,357 | -$7,824 | -$35,821 |
| % Margin | – | – | – | – |
| EPS | -1.22 | -7.65 | -23.2 | -23.66 |
| % Growth | 84.1% | 67% | 1.9% | – |
| EPS Diluted | -1.22 | -7.65 | -23.2 | -23.66 |
| Weighted Avg Shares Out | 11,246 | 4,490 | 1,535 | 1,514 |
| Weighted Avg Shares Out Dil | 11,246 | 4,490 | 1,535 | 1,514 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $126 |
| Interest Expense | $0 | $110 | $132 | $126 |
| Depreciation & Amortization | $58 | $58 | $52 | $519 |
| EBITDA | -$24,146 | -$38,017 | -$7,640 | -$35,302 |
| % Margin | – | – | – | – |